Article Information
History
- June 26, 2017.
Article Versions
- Version 1 (June 23, 2017 - 10:43).
- You are currently viewing Version 2 of this article (June 26, 2017 - 11:23).
- Version 3 (June 28, 2017 - 10:23).
- Version 4 (August 8, 2017 - 07:44).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- NR Naylor1*,
- KB Pouwels2,4,
- R Hope3,
- N Green4,
- KL Henderson3,
- GM Knight1,
- R Atun5,1,
- JV Robotham2,1 and
- SR Deeny6
- 1National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, W12 0NN
- 2Modelling and Economics Unit, National Infection Service, Public Health England, London, England.
- 3Healthcare Associated Infection and Antimicrobial Resistance Department, Public Health England, London, England.
- 4Department of Infectious Disease Epidemiology, Imperial College London, England.
- 5Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States.
- 6The Health Foundation, London, England.